SCHEMBL31660436

SCHEMBL31660436

CCOC(=O)c1cccc(-c2noc(-c3ccccc3F)n2)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.78
RAB9A P51151 11/20 0.78
MAOA P21397 1/20 0.69
BLVRB P30043 1/20 0.69
HDAC6 Q9UBN7 1/20 0.69
ALDH1A1 P00352 3/20 0.56
LMNA P02545 1/20 0.56
TSHR P16473 1/20 0.56
SMN1; SMN2 Q16637 6/20 0.55
KMT2A Q03164 4/20 0.55
NFKB1 P19838 3/20 0.55
NFKB2 Q00653 3/20 0.55
RELA Q04206 3/20 0.55
MEN1 O00255 3/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
PKM P14618 2/20 0.55
MAPK1 P28482 2/20 0.55
MAPT P10636 2/20 0.51
TP53 P04637 1/20 0.51
GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26092403 1.00 NPC1 (0.78) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL60513 0.88 NPC1 (0.77) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL29607696 0.88 NPC1 (0.77) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL59495 0.87 NPC1 (1.00) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL30008519 0.87 NPC1 (1.00) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL26463350 0.87 NPC1 (0.66) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL12171227 0.87 NPC1 (0.69) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL60719 0.86 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL60102 0.86 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6
SCHEMBL60583 0.86 NPC1 (0.72) NPC1RAB9AMAOABLVRBHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250228242-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250228242-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL APP, APBA1, PRNP NPC1 2456/4885RAB9A 1693/4885MAOA 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.